Carrum Health was selected as one of a few select innovators to participate in two Employer Health Innovation Roundtable (EHIR) meetings this fall, Cohort 3 and Cohort 4. Innovators were chosen by the twenty employers of Cohort 3 to present their solution in front of benefits leaders from Walgreens, Cargill, PepsiCo, AT&T, EY and others at The Home Depot headquarters in Atlanta. Cohort 4 took place at the CNA global headquarters in Chicago and included companies like Total Wine, ArcBest and UnitedAg.
According to the 2019 Kaiser Family Foundation Employer Health Benefits Survey, the employer share of health insurance premiums has increased by 71 percent in the past decade, and overall premiums have gone up 54 percent since 2009. EHIR provides global employers with information on the latest innovations in benefits through its exclusive cohort meetings.
NeuroFlow has hired Tim Kinner as the company’s senior director of business development. The new position was created in response to increased product demand, as more healthcare providers research and engage with behavioral health technology companies.
Twistle has raised $16 million in a Series A round. The company uses automated communication, information-gathering and patient education, to help manage patient populations and improve clinical and patient-reported outcomes. Growth equity firm Health Enterprise Partners and MemorialCare Innovation Fund led the round. The company also took part in the Mass Challenge 2019 health tech cohort. To read more, click here.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
FundamentalVR closed a $5.67 million Series A round to support its virtual reality surgical training platform. Downing Ventures led the round with but Tern PLC, Epic Private Equity and Brighteye Ventures also participated. To read more, click here.
Medtech business Cytovale raised $7.4 million in an extension of its Series B round, bringing the total raised for the round to $15 million. The funding is intended to support advancement of its tool for early detection of sepsis in the emergency department. Existing investors Breakout Ventures and Blackhorn Ventures co-led the round and Western Technology Investment also participated. To read more, click here.
Picture: akindo, Getty Images
